Relationship of demographic and clinical factors to free and total prostate-specific antigen

Urology

Volumn 58, Issue 4, 2001, Pages 561-566

  Gelmann, Edward P ^a   Chia, David ^b   Pinsky, Paul F ^c   Andriole, Gerald L ^d   Crawford, E David ^e   Reding, Douglas ^f   Hayes, Richard B ^c   Kramer, Barnett S ^g   Woodrum, David L ^h   Gohagan, John K ^c   Levin, David L ^c  

^a GEORGETOWN UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d WASHINGTON UNIVERSITY   (United States)

^e UNIVERSITY OF COLORADO   (United States)

^f MARSHFIELD CLINIC   (United States)

^g NATIONAL INSTITUTES OF HEALTH   (United States)

^h BECKMAN COULTER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; IBUPROFEN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ARTICLE; ASIAN; CANCER SCREENING; CAUCASIAN; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; DEMOGRAPHY; ETHNIC GROUP; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; RANDOMIZED CONTROLLED TRIAL; SMOKING; VASECTOMY;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; HISPANIC AMERICANS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; SENSITIVITY AND SPECIFICITY;

EID: 0034811531     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(01)01305-X     Document Type: Article

References (27)

1. Prostate cancer screening; what we know and what we need to know
2. Cancer surveillance series; interpreting trends in prostate cancer. Part I. Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates
3. Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer; receiver operating characteristic curves
4. Longitudinal analysis of serial measurements of free and total PSA among men with and without prostatic cancer
5. Association of free PSA percent, total PSA, age, and gland volume in the detection of prostate cancer
6. Significance of free to total PSA ratio in men with slightly elevated serum PSA levels; a cooperative study
7. The clinical utility of measuring free-to-total prostate-specific antigen (PSA) ratio and PSA density in differentiating between benign prostatic hyperplasia and prostate cancer
8. Free-to-total prostate-specific antigen (PSA) ratio improves the specificity for detecting prostate cancer in patients with prostatism and intermediate PSA levels
9. Free/total PSA ratio improves differentiation of benign and malignant disease of the prostate; critical analysis of two different test populations
10. Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer
11. Clinical evaluation of free PSA/total PSA (prostate-specific antigen) ratio in the diagnosis of prostate cancer
12. Improvement of prostate cancer screening by determination of the ratio free/total PSA in addition to PSA levels
13. Interpretation of free prostate specific antigen clinical research studies for the detection of prostate cancer
14. Age specific prostate specific antigen reference ranges; population specific
15. Improvement of specificity in PSA-based screening by using PSA-transition zone density and percent free PSA in addition to total PSA levels
16. Age-related free PSA, total PSA and free PSA/total PSA ratios; establishment of reference ranges in Chinese males
17. Race and serum prostate-specific antigen levels; current status and future directions
18. Prostate-specific antigen levels are higher in African-American than in white patients in a multicenter registration study; results of RTOG 94-12
19. Comparison of serum prostate-specific antigen levels and PSA density in African-American, white, and Hispanic men without prostate cancer
20. Age- and race-specific reference ranges for prostate-specific antigen from a large community-based study
21. Prostate-specific antigen concentration; influence of age and ethnicity
22. Age-specific reference ranges for prostate-specific antigen in black men
23. Serum levels of prostate-specific antigen among Japanese-American and native Japanese men
24. Plasma free and non-sex-hormone-binding-globulin-bound testosterone are decreased in obese men in proportion to their degree of obesity
25. Effects of chronic smoking on testosterone metabolism in dogs